This document is an excerpt from the EUR-Lex website
Document 32025D1247
Commission Implementing Decision (EU) 2025/1247 of 26 June 2025 repealing Implementing Decision (EU) 2024/2460 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2025/1247 of 26 June 2025 repealing Implementing Decision (EU) 2024/2460 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2025/1247 of 26 June 2025 repealing Implementing Decision (EU) 2024/2460 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
C/2025/3995
OJ L, 2025/1247, 27.6.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1247/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
No longer in force, Date of end of validity: 17/07/2025
|
Official Journal |
EN L series |
|
2025/1247 |
27.6.2025 |
COMMISSION IMPLEMENTING DECISION (EU) 2025/1247
of 26 June 2025
repealing Implementing Decision (EU) 2024/2460 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 14(5) thereof,
After consulting the Standing Committee on Biocidal Products,
Whereas:
|
(1) |
Metofluthrin was included in Annex I to Directive 98/8/EC of the European Parliament and of the Council (2) as an active substance for use in biocidal products of product-type 18. Pursuant to Article 86 of Regulation (EU) No 528/2012, it was therefore considered approved until 30 April 2021 under that Regulation subject to the conditions set out in Annex I to Directive 98/8/EC. |
|
(2) |
On 25 October 2019, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of metofluthrin for use in biocidal products of product-type 18 (‘the application’). The application was evaluated by the competent authority of Ireland. |
|
(3) |
Pursuant to Commission Implementing Decision (EU) 2021/327 (3), the expiry date of approval of metofluthrin for use in biocidal products of product-type 18 was postponed to 31 October 2023. That expiry date was further postponed to 31 October 2024 by Commission Implementing Decision (EU) 2023/1086 (4), and to 30 April 2026 by Commission Implementing Decision (EU) 2024/2460 (5) in order to allow sufficient time for the examination of the application. |
|
(4) |
Commission Implementing Regulation (EU) 2025/1248 (6) renewed the approval of metofluthrin (renamed to epsilon-metofluthrin) for use in biocidal products of product-type 18, subject to the conditions in the Annex to that Regulation, including the expiry date of approval. Therefore, it is appropriate to repeal Implementing Decision (EU) 2024/2460 postponing the initial expiry date of the approval of metofluthrin, |
HAS ADOPTED THIS DECISION:
Article 1
Implementing Decision (EU) 2024/2460 is repealed.
Article 2
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Done at Brussels, 26 June 2025.
For the Commission
The President
Ursula VON DER LEYEN
(1) OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj.
(2) Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1, ELI: http://data.europa.eu/eli/dir/1998/8/oj).
(3) Commission Implementing Decision (EU) 2021/327 of 23 February 2021 postponing the expiry date of approval of metofluthrin for use in biocidal products of product-type 18 (OJ L 64, 24.2.2021, p. 10, ELI: http://data.europa.eu/eli/dec_impl/2021/327/oj).
(4) Commission Implementing Decision (EU) 2023/1086 of 2 June 2023 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 144, 5.6.2023, p. 96, ELI: http://data.europa.eu/eli/dec_impl/2023/1086/oj).
(5) Commission Implementing Decision (EU) 2024/2460 of 16 September 2024 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/2460, 17.9.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/2460/oj).
(6) Commission Implementing Regulation (EU) 2025/1248 of 26 June 2025 renewing the approval of epsilon-metofluthrin as an active substance for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1248, 27.6.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/1248/oj).
ELI: http://data.europa.eu/eli/dec_impl/2025/1247/oj
ISSN 1977-0677 (electronic edition)